Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
基本信息
- 批准号:8686719
- 负责人:
- 金额:$ 60.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAffectAmino AcidsAnimal ModelAnimalsAntiviral AgentsBindingBiochemicalBiological AssayBiologyCell Culture TechniquesCommon ColdComplexConsensusConsensus SequenceCoronavirusCoronavirus InfectionsCroupDeubiquitinating EnzymeDeubiquitinationDevelopmentDisease OutbreaksDockingEngineeringEnzymesExhibitsGenomicsGoalsHomology ModelingHumanImmune responseIntegration Host FactorsInterferon-betaInterferonsInterventionKineticsLigand BindingLung diseasesMediatingMethodsModelingMolecularMusMutagenesisMutationNatural ImmunityPapainPathogenesisPathway interactionsPeptide HydrolasesPhenotypePolyproteinsPredispositionProcessProtease DomainProtein BindingProteinsRNARNA VirusesReporterResearchRoentgen RaysRoleSequence HomologySevere Acute Respiratory SyndromeSindbis VirusSiteSite-Directed MutagenesisSpecificityStructureSubstrate SpecificitySurfaceSymptomsTestingThermodynamicsTranslatingTransmembrane DomainUbiquitinVaccinesViralViral PathogenesisVirusVirus DiseasesVirus Replicationcellular targetingdesigndrug developmentimprovedinsightmouse modelmutantnew therapeutic targetnovelnovel therapeuticspositional cloningprotein protein interactionreplicaseresearch studyresponseubiquitin isopeptidasevaccine developmentvirus pathogenesis
项目摘要
DESCRIPTION (provided by applicant): The long term goal of our research is to determine the role of viral protease and interferon antagonism activity in coronavirus replication and pathogenesis. Coronaviruses are positive strand RNA viruses which cause a range of illness, from relatively mild respiratory disease (croup and common cold like symptoms due to HCoV- NL63, 229e or OC43) to severe acute respiratory syndrome (SARS) outbreaks in humans. To date, there are no effective vaccines or antiviral drugs to limit the pathogenesis of any coronavirus infection. Clearly, we need to identify and understand the viral and host factors that contribute to efficient viral replication and pathogenesis to aid in the development of new therapeutics. Previously, we identified the papain-like protease (PLpro) of SARS-CoV as a critical determinant of viral replication and pathogenesis. During coronavirus replication, the input genomic RNA is translated to produce a replicase polyprotein which must be processed by viral papain-like and 3C-like proteases to generate the replication complex. We showed that PLpro processes the replicase polyprotein at three sites using a consensus recognition site of LXGG, similar to the consensus sequence recognized by de-ubiquitinating enzymes (DUBs). We solved the X-ray crystal structure of PLpro and demonstrated that it is indeed a DUB. However, the role of its viral DUB activity in pathogenesis remains to be determined. In addition, we found that PLpro exhibits interferon antagonism activity and that catalytic activity may not be required for full interferon antagonism. We hypothesize that distinct residues within the papain-like protease domain of coronaviruses are critical for mediating substrate specificity and interferon antagonism and that identification of these sites will provide novel targets for antiviral intervention. Here, we propose to investigate the biology of coronavirus papain-like proteases by comparing and contrasting the activity of papain-like proteases of SARS-CoV, HCoV-NL63, and murine coronavirus A59. Our specific aims are to: 1) Identify sites within the papain-like protease domains that are critical for polyprotein processing, deubiquitinating and deISGylating activity; 2) Determine residues within coronavirus papain-like proteases that are important for interferon antagonism and identify cellular proteins that interact with PLPs to block innate immunity; 3) Determine the domains, amino acids, and binding energies involved in protein-protein interactions between papain-like proteases and their binding partners; and 4) Determine if mutation of the PLpro or PLP2 domain alters evasion of ubiquitin- or ISG15-dependent innate immune responses. The results from this research will allow us to identify critical sites that mediate specificity of papain-like proteases and provide new insight into viral mechanisms for pathogenesis and evasion of the innate immune response.
描述(由申请人提供):我们研究的长期目标是确定病毒蛋白酶和干扰素拮抗活性在冠状病毒复制和发病机制中的作用。冠状病毒是正链RNA病毒,其引起一系列疾病,从相对轻微的呼吸道疾病(由于HCoV-NL 63、229 e或OC 43引起的哮吼和普通感冒样症状)到人类严重急性呼吸综合征(SARS)爆发。到目前为止,还没有有效的疫苗或抗病毒药物来限制任何冠状病毒感染的发病机制。显然,我们需要识别和了解有助于有效病毒复制和发病机制的病毒和宿主因素,以帮助开发新的治疗方法。在此之前,我们确定了SARS-CoV的木瓜蛋白酶样蛋白酶(PLpro)作为病毒复制和致病的关键决定因素。在冠状病毒复制期间,输入基因组RNA被翻译以产生复制酶多蛋白,其必须被病毒木瓜蛋白酶样蛋白酶和3C样蛋白酶加工以产生复制复合物。我们发现,PLpro过程中的复制酶多聚蛋白在三个网站使用的共识识别位点LXGG,类似的共识序列识别的去泛素化酶(DUBs)。我们解决了PLpro的X射线晶体结构,并证明它确实是DUB。然而,其病毒DUB活性在发病机制中的作用仍有待确定。此外,我们发现PLpro具有干扰素拮抗活性,并且完全干扰素拮抗可能不需要催化活性。我们假设冠状病毒木瓜蛋白酶样蛋白酶结构域内的不同残基对于介导底物特异性和干扰素拮抗作用至关重要,并且这些位点的鉴定将为抗病毒干预提供新的靶点。在这里,我们建议通过比较和对比SARS-CoV,HCoV-NL 63和鼠冠状病毒A59的木瓜蛋白酶样蛋白酶的活性来研究冠状病毒木瓜蛋白酶样蛋白酶的生物学。我们的具体目标是:2)确定冠状病毒木瓜蛋白酶样蛋白酶内对干扰素拮抗作用重要的残基,并鉴定与PLPs相互作用以阻断先天免疫的细胞蛋白; 3)确定木瓜蛋白酶样蛋白酶与其结合伴侣之间蛋白质-蛋白质相互作用所涉及的结构域、氨基酸和结合能;和4)确定PLpro或PLP 2结构域的突变是否改变泛素或ISG 15依赖性先天免疫应答的逃避。这项研究的结果将使我们能够确定介导木瓜蛋白酶样蛋白酶特异性的关键位点,并为先天免疫应答的发病机制和逃避提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan C. Baker其他文献
THE CONVERGENCE OF MULTIPLE MODELS OF MOTIVATION FOR SECOND LANGUAGE LEARNING : GARDNER
第二语言学习多种动机模式的融合:加德纳
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
Maclntyre;Keith MacMaster;Susan C. Baker;Univasitl Colhge d Ca - 通讯作者:
Univasitl Colhge d Ca
A chimeric virus-mouse model system for evaluating the function A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses and inhibition of papain-like proteases of emerging coronaviruses
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Susan C. Baker - 通讯作者:
Susan C. Baker
Overcome imposter syndrome: Contribute to working groups and build strong networks
克服冒名顶替综合症:为工作组做出贡献并建立强大的网络
- DOI:
10.1016/j.biocon.2024.110566 - 发表时间:
2024 - 期刊:
- 影响因子:5.9
- 作者:
Amanda E. Bates;Megan A. Davies;Rick D. Stuart;Natali Lazzari;J. Lefcheck;Scott D. Ling;Camille Mellin;David Mouillot;Anthony T.F. Bernard;Scott Bennett;Christopher J. Brown;Michael T. Burrows;Claire L. Butler;J. Cinner;Ella Clausius;Antonia T. Cooper;Mark John Costello;Lara Denis;Graham J. Edgar;Yann Herrera Fuchs;Olivia J. Johnson;Cesc Gordó;Cyril Hautecoeur;Leah M. Harper;F. Heather;Tyson R. Jones;Anthony C. Markey;E. Oh;Matthew Rose;Paula A. Ruiz;José A. Sanabria;Jasmin M. Schuster;Joanna K. Schmid;Susan C. Baker - 通讯作者:
Susan C. Baker
Timing and frequency are the critical factors affecting the impact of defoliation on long term growth of plantation eucalypts
- DOI:
10.1016/j.foreco.2017.02.004 - 发表时间:
2017-05-01 - 期刊:
- 影响因子:
- 作者:
Jane A. Elek;Susan C. Baker - 通讯作者:
Susan C. Baker
Monoclonal Antibodies From Children With Acute Kawasaki Disease Identify a Common Antigenic Target in Fatal Cases Over 5 Decades
来自急性川崎病患儿的单克隆抗体在50多年的致死病例中识别出一个共同的抗原靶点
- DOI:
10.1016/j.labinv.2025.104131 - 发表时间:
2025-06-01 - 期刊:
- 影响因子:4.200
- 作者:
Anne H. Rowley;Robert Byrd;David Arrollo;Amornrat O’Brien;Stanford Shulman;Masaru Terai;Kwang-Youn Kim;Kassandra Mercado;Kristine Wylie;Robert Fialkowski;Susan C. Baker - 通讯作者:
Susan C. Baker
Susan C. Baker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan C. Baker', 18)}}的其他基金
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10206579 - 财政年份:2021
- 资助金额:
$ 60.25万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10882676 - 财政年份:2021
- 资助金额:
$ 60.25万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10449132 - 财政年份:2021
- 资助金额:
$ 60.25万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10657457 - 财政年份:2021
- 资助金额:
$ 60.25万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8099729 - 财政年份:2010
- 资助金额:
$ 60.25万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
7987943 - 财政年份:2010
- 资助金额:
$ 60.25万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
9096719 - 财政年份:2010
- 资助金额:
$ 60.25万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8291352 - 财政年份:2010
- 资助金额:
$ 60.25万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8485522 - 财政年份:2010
- 资助金额:
$ 60.25万 - 项目类别:
Bronchial Epithelial Cultures and Kawasaki Disease
支气管上皮培养与川崎病
- 批准号:
7599596 - 财政年份:2008
- 资助金额:
$ 60.25万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 60.25万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 60.25万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 60.25万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 60.25万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 60.25万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 60.25万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 60.25万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 60.25万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 60.25万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 60.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists